pharmaphorum

SEPTEMBER 1, 2022

Cyrus Massoumi, founder of Dr. B, tells us about his online platform that makes physician assessment readily available to patients and provides access to COVID-19 therapeutics that may otherwise be difficult to obtain. Dr. B was founded in 2021 to connect providers with leftover COVID vaccines to the patients seeking to receive them.

Medical 96

Medical Prescription Doctors Physicians 96

Pharmaceutical Technology

JUNE 14, 2023

Ipsen has received US Food and Drug Administration (FDA) approval for Bylvay (odevixibat) to treat patients aged 12 months and above with cholestatic pruritus caused by Alagille syndrome (ALGS). More than 90% of patients who received treatment with odevixibat were pruritus responders.

Food and Drug Administration 52

Food and Drug Administration FDA Transportation Prescription 52

pharmaphorum

SEPTEMBER 30, 2022

Patient organisations have been celebrating the FDA approval yesterday of Amylyx’ amyotrophic lateral sclerosis (ALS) therapy Relyvrio, after not one but two advisory committee meetings that arrived at different conclusions about the drug. An oral version of edaravone was cleared this year.

FDA 89

FDA Doctors Patients Prescription 89

Pharmaceutical Technology

AUGUST 12, 2022

In the lead-up to a critical meeting that will influence the approval of a new drug for amyotrophic lateral sclerosis (ALS), the US Food and Drug Administration (FDA) has detailed its plans to advance rare neurodegenerative disease research. The FDA’s action plan. Thus, FDA funding could be what is needed on this front, says Cudkowicz.

FDA 98

FDA Food and Drug Administration Physicians Side effects 98

Legacy MEDSearch

JUNE 15, 2023

Cala , the bioelectronic medicine leader setting a new standard of care for chronic disease, today announced the commercial launch of its next generation system: the Cala kIQ System, the first and only FDA-cleared wearable device that delivers effective therapy for action hand tremor relief in people with essential tremor and Parkinson’s disease.

Patients 98

Patients Recruitment Pharmacology Side effects 98

Pharmaceutical Technology

JULY 20, 2022

On 6 July, in an effort to accelerate access, the US Food and Drug Administration (FDA) allowed pharmacists to also begin prescribing the drug to eligible individuals with Covid-19. Previously, only licensed and authorised physicians, advanced practice registered nurses, and physician assistants could prescribe the drug. .

Food and Drug Administration 111

Food and Drug Administration Physicians Prescription Medical 111

World of DTC Marketing

NOVEMBER 5, 2021

Patients want quick fixes, and the idea of losing some weight because of a new drug is enticing to them. In response, the company has been providing six-month waivers to some insured patients that will cap the drug’s out-of-pocket costs at $25 a month, though the long-term picture of coverage is still in flux. Click to Tweet.

Insurance 271

Insurance Side effects Prescription Medical 271

PM360

AUGUST 9, 2022

According to a 2021 study by Statista, 40% of prescriptions written in 2005 were for brand-name medications. 1 How is this possible, given that more than 20,000 prescription drugs are currently in circulation in the U.S. 2 and over a million actively licensed physicians 3 are available to prescribe them?

Prescription 52

Prescription Doctors Specialization Physicians 52

World of DTC Marketing

JULY 5, 2022

Pharma websites provide the prescription that can help people overcome health problems but too often, they ignore the patient’s responsibility to lose weight and exercise. The FDA should require every pharma product website to devote part of its content to prevention and the importance of exercise.

Insurance 200

Insurance Doctors Side effects Pharma 200

Legacy MEDSearch

MARCH 15, 2023

The acquisition extends HeartBeam’s reach in remote monitoring and detection with full ownership of an existing cutting-edge FDA-cleared product. Founded in 2016, LIVMOR developed the Halo+ Atrial Fibrillation (AF) Detection System, the world’s first FDA-cleared prescription wearable for continuous cardiac rhythm monitoring.

Food and Drug Administration 97

Food and Drug Administration FDA Recruitment Physicians 97

PM360

SEPTEMBER 15, 2022

based physicians reveals that a majority are concerned and confused about what constitutes a life-threatening emergency that would make an abortion procedure legal in those 11 states where it has been banned. Patient Pages: Patients Refuse Prescription Use After Recalls. Doctor Docs: Doctors Left Concerned After Roe v.

Healthcare 52

Healthcare Healthcare Doctors Physicians 52

PM360

OCTOBER 13, 2023

HCPs need pharma, and pharma needs HCPs—so let’s make sure that this next chapter of engagement is one of partnership, in pursuit of the interest of patients.” Only 15% of prescribers think the drugs come at reasonable cost to patients or have decent insurance coverage eligibility. Three quarters of U.S.

Healthcare 59

Healthcare Healthcare Doctors Pharma 59

PM360

AUGUST 9, 2022

How can we help ensure patients continue to take their medications as prescribed? The reasons why a patient may not take their medication are plentiful, and as a result so are the solutions now available to attempt to solve this issue. But it is not a simple answer. Furthermore, it is estimated to reach $6.5 Vincent Keunen.

Prescription 105

Prescription Medical Side effects Patients 105

Pharmaceutical Technology

SEPTEMBER 23, 2022

Current treatment options for DES are dominated by a mix of prescription and over-the-counter (OTC) products. Artificial tears are also used extensively in conjunction with prescription therapies for symptomatic relief. Novaliq/ Bausch + Lomb’s NOV-3 (perfluorohexyloctane) is also currently at pre-registration stage with the FDA.

Prescription 59

Prescription Physicians FDA Marketing 59

pharmaphorum

DECEMBER 22, 2022

The life sciences industry is flexing towards innovation in new areas, faster than ever before, and increasing patient care in astonishing ways. We can now measure patient activity, steps, and movement continuously and in real time, which serves as a new potential indicator of treatment effectiveness.

FDA 87

FDA Patients Electronics Medical 87

European Pharmaceutical Review

NOVEMBER 8, 2022

In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. Citizen Petitions before the FDA. 2 Submission of a Citizen Petition to the FDA obligates the regulator to address the arguments raised. 5) monitoring access to biosimilars. Senate Bill 562 (S.

Food and Drug Administration 52

Food and Drug Administration Pharma Prescription Manufacturing 52

Clarivate

JULY 5, 2023

The month of July could see seven FDA-approved adalimumab biosimilars launch in the United States, an unprecedented situation for a market that has been relatively slow to embrace biosimilars. biologics market and reduce prescription drug costs. biologics market and reduce prescription drug costs.

Marketing 97

Marketing Physicians Manufacturing Competition 97

pharmaphorum

AUGUST 11, 2022

More than 60 percent of all American adults take prescription drugs , amounting to approximately 131 million individuals. There have been great strides made in genomics to refine tools that determine the safest, most effective course of treatments for patients across a number of disease states. billion in the United States alone.

Side effects 92

Side effects Medical Prescription Patients 92

pharmaphorum

DECEMBER 15, 2022

Wise is also working on different versions of the software that will be developed as prescription DTx, with the objective of securing FDA approvals. “With this partnership, we aim to help patients combat mental health issues and make the process seamless for clinicians,” he added.

Education 52

Education Electronics Prescription Physicians 52

Pharmaceutical Representative Training

DECEMBER 28, 2021

Before 2020, the landscape of drug marketing involved following drug approvals by the Food and Drug Administration ( FDA ), finding which patient population would benefit from therapy, and visiting specialized doctors in-person to advertise its advantages compared to current guidelines. The technology identifies.

Marketing 52

Marketing Food and Drug Administration Pharma Doctors 52

Legacy MEDSearch

OCTOBER 25, 2023

She emphasized the significance of these findings stating, “When assessing the clinical benefits of therapies for chronic neurological disorders such as migraine, it’s important to evaluate patient adherence and clinical efficacy over a long period of time, in order to eliminate possible tachyphylaxis or waning over time.

Side effects 52

Side effects Recruitment Networking Management 52

World of DTC Marketing

SEPTEMBER 22, 2021

Visting my doctor for my annual physical, I noticed huge LCD screens in each exam room with rotating ads for everything from prescription drugs to vitamins. Second, do people trust the FDA? ” 2wo: Physicians are still the gatekeepers of new Rx’s. Diabetes customers are different than MS patients. 5ive: Please!

Doctors 43

Doctors Media Marketing Prescription 43

Evolve Your Success

OCTOBER 3, 2023

Veronica discusses a revolutionary technology for testing and how it’s transforming the way physicians and patients approach cancer treatment. She also takes us through the ins and outs of her role, from tracking patient progress to delivering crucial results. There are many terms in medical sales. This sounds fascinating.

Sales 64

Sales Medical sales Physicians Medical 64

pharmaphorum

JULY 7, 2022

Pfizer is still waiting for the green light to complete an acquisition of digital health company ResApp, a deal that looks even better now that its smartphone app for people with obstructive sleep apnoea (OSA) has been approved by the FDA. The post ResApp bags FDA okay for sleep apnoea app, after Pfizer takeover bid appeared first on.

FDA 104

FDA Prescription Healthcare Provider Physicians 104

pharmaphorum

JUNE 29, 2022

The prescription medicine market has recovered from the wild swings of the early pandemic with renewed growth. Non-COVID prescription medicines didn’t stop launching during the pandemic — approvals by both the FDA and the EMA were, in fact historically high in both 2020 and 2021. The scope of the problem.

Doctors 57

Doctors Medicine Marketing Prescription 57

Clarify Health

MAY 19, 2020

The time-consuming and resource-intensive path from the lab bench to the patient bedside starts with drug discovery, progresses to pre-clinical and clinical research, and then enters regulatory review. After FDA-approval comes the last critical mile of this journey: bringing the product to market. Which physicians see these patients?

Biopharma 52

Biopharma Physicians Marketing Prescription 52

Pharmaceutical Technology

AUGUST 8, 2022

In 2017, the US Food and Drug Administration (FDA) broke ground by approving the first drug with an embedded biosensor to track its use. Proteus Health’s Abilify MyCite had an ingestible sensor that could track if a patient consumed the drug. Yet, despite the landmark FDA approval, digital pills have not exploded in pharma.

Food and Drug Administration 122

Food and Drug Administration FDA Medicine Patients 122

Nixon Gwilt Law

JANUARY 16, 2024

Companies will also need to understand whether the FDA will consider their model to be software as a medical device (SaMD) that is subject to the FD&C Act. What started as a drug to help patients with Type 2 diabetes is now the preferred weight loss aid of many celebrities, influencers, and everyday people.

Healthcare 52

Healthcare Healthcare Management Insurance 52

PM360

DECEMBER 14, 2022

In its latest venture into the healthcare arena, Amazon is reaching out directly to the consumer via its soon-to-be-launched Amazon Clinic , a virtual health service for patients to see licensed clinicians about common medical issues. So far, the FDA has only granted the interchangeability status to four of the 39 biosimilars it has approved.

Manufacturing 52

Manufacturing Medical Healthcare Healthcare 52

Pharmaceutical Technology

OCTOBER 25, 2022

Pharmaceutical companies – and the FDA – are embracing FDCs. From 1990 through 2013, the FDA approved 131 FDC products, on average 5.7 From 1990 through 2013, the FDA approved 131 FDC products, on average 5.7 Between 2010 and the end of 2015, of the 655 New Drug Applications (NDAs) approved by the FDA, 63 were for FDCs.

Manufacturing 52

Manufacturing Physicians Prescription FDA 52

Quantified

APRIL 18, 2022

In the context of a new medical innovation where there is a high unmet patient need, this means patients are not getting rapid access to medicines that can positively impact or even extend their lives. Prescription medicine companies simply have fewer ways of reaching audiences at scale compared to nearly any other industry.

Sales 52

Sales Pharma Pharma sales reps Medicine 52

Cadensee

JULY 20, 2021

He is one of the first advocates for patient centric health care more than a decade ago when patient opinions and requests were not part of the equation in the system. Uri founded and continues to contribute insights through his digital magazine, e-Pochonder and is one of the first advocates for patient centric health care.

Food and Drug Administration 52

Food and Drug Administration Doctors Healthcare Healthcare 52

Nixon Gwilt Law

NOVEMBER 5, 2021

The IFR and ETS complement each other, with both aimed at furthering the Biden Administration’s goal of vaccinating the entire United States healthcare workforce to ensure capacity to serve local and national healthcare needs, the safety of the workforce and patients, and to reduce the risk of continued COVID-19 transmission.

Healthcare 52

Healthcare Healthcare Training Safety 52

Pharmaceutical Technology

DECEMBER 4, 2022

There are seven FDA-approved Humira biosimilars, of which Amgen’s Amjevita will be launched in January. At the same time, Cross says that this is not up to clinicians or the patients, but the payers. Product variation creates patient uncertainty. Citrate could also make these products unsatisfactory to the patients, says Cross.

Marketing 104

Marketing Physicians Competition Patients 104